Lilly has reported comprehensive outcomes from the Phase III trial of tirzepatide for individuals with heart failure with ...

The trial is structured as a non-randomised, open-label study in patients with relapsed, resistant or metastatic HPV-related ...

Characterised by the overproduction of skin cells, plaque psoriasis leads to itchy or painful inflamed and scaly plaques. Credit: And-One / Shutterstock. Johnson & Johnson (J&J) has reported positive ...

At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.

New data from Barinthus Bio's HBV003 trial has demonstrated durable HBsAG loss in participants with chronic hepatitis B.

The topline results found that the TenNor rifasutenizol trial showed better safety and tolerability than the current standard ...

Gilead Sciences has reported two-and-a-half-year interim analysis outcomes from a Phase III study of Livdelzi (seladelpar) ...

The failure of the Eyenovia CHAPERONE study has seen the company’s stock value drop drastically as it weighs up options and ...

The discussion at AHA emphasised that the FLOW trial established that semaglutide prevents major kidney outcomes and major ...

The ASI drug class potentially fills an unmet need in the CKD space. Credit: crystal light via Shutterstock. On 15 November ...

GlobalData forecasts that the prostate cancer market is set to increase by 25% from $475.84 million in 2024 to $596.22 ...

Atrial flutter is a type of abnormal heart rhythm that causes rapid and irregular beating of the upper chambers of the heart. Credit: Rawpixel.com via Shutterstock. Intellia Therapeutics has announced ...